This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43698829
rdf:type
wikibase:Item
schema:description
научная статья 2001年学术文章 artikulong pang-agham article scientifique scientific article published in August 2001 2001年の論文 bài báo khoa học article científic 2001年學術文章 wissenschaftlicher Artikel artikel ilmiah scientific article published in August 2001 artigo científico vitskapeleg artikkel מאמר מדעי artículo científico publicado en 2001 articolo scientifico wetenschappelijk artikel article scientific 2001年學術文章 บทความทางวิทยาศาสตร์ επιστημονικό άρθρο 2001年学术文章 2001年学术文章 наукова стаття, опублікована в серпні 2001 სამეცნიერო სტატია مقالة علمية نشرت في أغسطس 2001 bilimsel makale 2001年学术文章 artigo científico vitenskapelig artikkel 2001年學術文章 scientific article published in August 2001 teaduslik artikkel vedecký článok videnskabelig artikel научна статия artikull shkencor 2001年學術文章 artykuł naukowy мақолаи илмӣ scienca artikolo 2001年学术文章 articol științific tieteellinen artikkeli আগস্ট ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vetenskaplig artikel artigo científico artículu científicu espublizáu en 2001 vědecký článek научни чланак 2001年學術文章 naučni članak tudományos cikk 2001 nî lūn-bûn 2001년 논문 научни чланак 2001年学术文章
p:P577
wds:Q43698829-DB249BD5-9910-4F60-ABBF-85D1BEB936A2
wdt:P577
2001-08-01T00:00:00Z
p:P407
wds:Q43698829-D71BDDDB-E08B-4B23-BCE2-3DFF4705E774
wdt:P407
wd:Q1860
p:P2860
wds:Q43698829-AFC8E95E-A6DA-45D5-AAFE-C10A7C6990C4 wds:Q43698829-C95F5225-D63E-4269-A4AD-52917AF9AE70 wds:Q43698829-CB43B4F2-2A2F-42B9-A0FF-A49B01C45D1E wds:Q43698829-E15ECDC7-782F-457A-AD27-CB8942952AAE wds:Q43698829-E4D0A115-C620-4C2F-A143-9F3E223EFBEE wds:Q43698829-152393FE-D450-452E-A5D5-9928B32517B8 wds:Q43698829-38C6B7D6-E519-44E2-8B20-DE2269AE9A54 wds:Q43698829-433C83F8-B7E6-49F1-A128-AD84FD8E63EF wds:Q43698829-573236BA-9147-4017-A43E-1AF95845EC42 wds:Q43698829-82C22E35-5CCB-4768-9BBD-90982BF65328 wds:Q43698829-9D3B840A-4C0D-4727-B6D7-915FCC3CFD27 wds:Q43698829-A9D09579-7912-4DF2-B4A2-3D84DD89ADAC
wdt:P2860
wd:Q32063342 wd:Q72743475 wd:Q39535867 wd:Q40403192 wd:Q34745427 wd:Q39443380 wd:Q28376281 wd:Q56995126 wd:Q45335490 wd:Q34001274 wd:Q42676268 wd:Q39465830
p:P2093
wds:Q43698829-42192504-E470-43A3-87AE-9BDDE9F43ADA wds:Q43698829-4285B806-B9A5-4DC7-AD9C-64BD775EC8E7 wds:Q43698829-C23FFA2D-8EC1-4850-B3A9-D2B3F7B73A26 wds:Q43698829-B93BFE26-7833-494D-9D62-0CEED3826ED9
wdt:P2093
Roehrborn CG Ginsberg PC Harkaway RC Baldwin KC
rdfs:label
Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia
skos:prefLabel
Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia
schema:name
Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia
p:P1476
wds:Q43698829-0706357B-9B2E-4382-AAAB-700183846AF6
wdt:P1476
Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia
p:P304
wds:Q43698829-ECA817A7-0A15-407F-85BB-C568EFB45E46
wdt:P304
203-209
p:P31
wds:Q43698829-F0CDB934-552A-4C98-A2A0-01A0EE6A8D78
wdt:P31
wd:Q13442814
p:P698
wds:Q43698829-C08634E6-59B2-4EEF-AD43-B34FDC68B524
wdtn:P698
n12:11489700
wdt:P698
11489700
p:P1433
wds:Q43698829-408D19F7-76F4-463C-9089-27AD029B6DA4
wdt:P1433
wd:Q7900884
p:P433
wds:Q43698829-84C6D4F5-E96E-4FFB-B5DA-AED52ADF5241
p:P478
wds:Q43698829-CA282BFC-234E-4AC8-BC55-BA70C952DC13
wdt:P433
2
wdt:P478
58
p:P356
wds:Q43698829-8A99C74C-708C-41BE-900A-30A7B55A6A2B
wdtn:P356
n10:S0090-4295(01)01201-8
wdt:P356
10.1016/S0090-4295(01)01201-8